AIM ImmunoTech (AIM) Other Accumulated Expenses (2015 - 2026)

AIM ImmunoTech (AIM) has 12 years of Other Accumulated Expenses data on file, last reported at $73000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses rose 35.19% year-over-year to $73000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73000.0 (up 35.19% YoY) and the FY2025 annual result came in at $190000.0, up 475.76% from the prior year.
• Other Accumulated Expenses declined to $73000.0 in Q1 2026, from $190000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $203000.0 in Q4 2022 to a low of $8000.0 in Q2 2024.
• A 5-year average of $91176.5 and a median of $75000.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses sank 90.24% — and 2025, when it surged 675.0%.
• Tracing AIM's Other Accumulated Expenses over 5 years: stood at $203000.0 in 2022, then slumped by 82.27% to $36000.0 in 2023, then fell by 8.33% to $33000.0 in 2024, then surged by 475.76% to $190000.0 in 2025, then slumped by 61.58% to $73000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $73000.0 (Q1 2026), $190000.0 (Q4 2025), and $75000.0 (Q3 2025), per Business Quant data.